Neovasc seeks HUD designation from FDA for Reducer
Neovasc, a speciality medical device company, has announced that it seeking FDA's designation for Neovasc Reducer as a…
Sign up to watch our free industry webinars.
Neovasc, a speciality medical device company, has announced that it seeking FDA's designation for Neovasc Reducer as a…
UK-based medical technology company LivaNova has launched its innovative arterial femoral cannula Bi-Flow, intended to prevent limb ischemia…
US-based health care company Abbott has secured the US Food and Drug Administration (FDA) approval for its advanced…
Digital health and medical technology firm Endotronix has enrolled first patient in the Sirona 11 trial of Cordella…
Neovasc has received guidance from the Food and Drug Administration (FDA) to consider potential alternate approaches for Humanitarian…
Meril's recently CE-approved MeRes100, used for the treatment of de-novo coronary artery lesions, has demonstrated zero scaffold thrombosis…
Keystone Heart announced that it has signed a distribution agreement with Ireland-based Vasorum for sales and marketing of…
OrSense, a leading developer of systems for non-invasive measurements of haemoglobin, announces the selection of its NBM-200 non-invasive…
Providence St. Joseph Health announced a multi-year strategic alliance to accelerate the digital transformation in its hospitals with…
Corindus Vascular Robotics, a leading developer of precision vascular robotics, announced today that Albert Einstein Jewish Hospital in…